Neurosteroid hormone vitamin D and its utility in clinical nutrition

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 10, Issue 1, 2007, Pages 12-19

  Kalueff, Allan V ^a,c   Tuohimaa, Pentti ^b  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Neurosteroid hormone; Supplementation and therapy; Vitamin D

Indexed keywords

ANTICONVULSIVE AGENT; ANTINEOPLASTIC AGENT; IMMUNOMODULATING AGENT; NEUROPROTECTIVE AGENT; NEUROSTEROID; NEUROTROPIC AGENT; PSYCHOTROPIC AGENT; VITAMIN D; VITAMIN D RECEPTOR;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; BRAIN AGING; BRAIN DISEASE; CALCIFICATION; CONTROLLED STUDY; HORMONAL REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOMODULATION; MOUSE; NERVOUS SYSTEM FUNCTION; NEUROMODULATION; NEUROPROTECTION; NEUROTRANSMITTER RELEASE; NONHUMAN; REGULATORY MECHANISM; REVIEW; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

ANIMALS; BRAIN; COGNITION DISORDERS; DIETARY SUPPLEMENTS; HUMANS; VITAMIN D; VITAMIN D DEFICIENCY; VITAMINS;

ANIMALIA;

EID: 33845438695     PISSN: 13631950     EISSN: 15353885     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328010ca18     Document Type: Review

References (105)

1. 3. Ann N Y Acad Sci 2006; 1068:194-203. An updated summary of multiple novel mechanisms of action of vitamin D in various target tissues.
2. DeLuca HF. Overview of general physiologic features and functions of vitamin D1-4. Am J Clin Nutr 2004; 80 (6 Suppl):1689-1896.
3. Holick MF. Resurrection of vitamin D deficiency and rickets. J Clin Invest 2006; 116:2062-2072. An excellent review on the growing incidence of vitamin D deficiency, summarizing the role of vitamin D in the prevention of rickets, and its importance in the overall health and welfare of infants and children.
4. Chaudhuri A. Why we should offer routine vitamin D supplementation in pregnancy and childhood to prevent multiple sclerosis. Med Hypotheses 2005; 64:608-615. A comprehensive review discussing pathogenetic mechanisms of MS and the preventive role of vitamin D-related supplementation in pregnancy and childhood.
5. 3. Biochemistry (Mosc) 2004; 69:738-741.
6. Kalueff AV, Minasyan A, Keisala T, et al. The vitamin D neuroendocrine system as a target for novel neurotropic drugs. CNS Neurol Disords Drug Targets 2006; 5:363-371.
7. Stumpf WE. Drug localization in tissues and cells: receptor microscopic autoradiography. Chapel Hills: IDDC Press; 2003.
8. Stumpf WE. The dose makes the medicine. Drug Discov Today 2006; 11:550-555.
9. 3. Science 1982; 215:1403-1405.
10. 3 sites of action in spinal cord and sensory ganglion. Anat Embryol 1988; 177:307-310.
11. 3 receptor immunoreactivity in the rat brain and spinal cord. J Chem Neuroanat 1999; 16:135-145.
12. 3 receptor immunoreactivity in the limbic system of the rat. Horm Metab Res 2001; 33:525-531.
13. 3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci Lett 2003; 343:139-143.
14. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13:100-105.
15. Eyles DW, Smith S, Kinobe R, et al. Distribution of the vitamin D receptor and 1α-hydroxylase in human brain. J Chem Neuroanat 2005; 29:21-30. The first report on the distribution and colocalization in human brain of vitamin D nuclear receptors and 1a-hydroxylase (the enzyme of vitamin D bioactivation). These findings support the role of the vitamin D system in human brain and imply that effective therapy of neuropsychiatric disorders can be based on targeting this system.
16. Langub MC, Herman JP, Malluche HH, Koszewski NJ. Evidence of functional vitamin D receptors in rat hippocampus. Neurosci 2001; 104:49-56.
17. McGrath J, Feron F, Eyles D, Mackay-Sim A. Vitamin D: the neglected neurosteroid? Trends Neurosci 2001; 24:570-572.
18. 3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology 1989; 97:285-294.
19. Kiraly SJ, Kiraly MA, Hawe RD, Makhani N. Vitamin D as a neuroactive substance: review. Sci World J 2006; 6:125-139. A comprehensive review focusing on different aspects of vitamin D action in the brain.
20. Obradovic D, Gronemeyer H, Lutz B, Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem 2005; 10:1-10. An important study showing in vitro that vitamin D interplays with other hormones, such as glucocorticoids, in the hippocampal cells. Vitamin D protects against glucocorticoid-induced cell death, likely to represent an additional mechanism of vitamin D/VDR-mediated neuroprotection.
21. Burne THJ, McGrath JJ, Mackay-Sim A, Eyles DW. Prenatal vitamin D deficiency and brain development. In: Stolzt VD, editor. Vitamin D: new research. New York: Nova Science; 2006. pp. 113-123. An excellent review on prenatal role of vitamin D in brain development.
22. 3 and brain development. Neuroscience 2003; 118:641-653.
23. Eyles DW, Rogers F, Buller K, et al. Developmental vitamin D (DVD) deficiency in the rat alters adult behaviours independently of HPA function. Psychoneuroendocrinology 2006; 31:958-964. An interesting report showing that hypothalamic-pituitary axis functions are normal in the maternally deficient animals, despite their pronounced behavioral alterations (hyperlocomotion). This is a clear demonstration that developmental factors strongly contribute to behavioral anomalies induced by vitamin D deficiency, suggesting that vitamin D pre/neonatal supplementation may help prevent certain developmental behavioral disorders in adults.
24. 3 deficiency alters the adult rat brain. Brain Res Bull 2005; 65:141-148.
25. 3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Dev Brain Res 2004; 153:61-68.
26. Mackay-Sim A, Feron F, Eyles D, et al. Schizophrenia, vitamin D, and brain development. Int Rev Neurobiol 2004; 59:351-380.
27. 3 - implications for brain development. J Steroid Biochem Mol Biol 2004; 89-90:557-560.
28. 3 metabolism in human glioblastoma multiforme: functionality of CYP27B1 splice variants, metabolism of calcidiol, and effects of calcitriol. Clin Cancer Res 2005; 11:5370-5380. This study, examining vitamin D metabolism in human glioblastoma cells, shows the complexity of modes of action, including both pro- and antiproliferative dose-dependent mechanisms of vitamin D and its metabolites.
29. Elias J, Marian B, Edling C, et al. Induction of apoptosis by vitamin D metabolites and analogs in a glioma cell line. Recent Results Cancer Res 2003; 164:319-321.
30. Zou J, Landy H, Feun L, et al. Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells. Biochem Pharmacol 2000; 60:1361-1365.
31. Agus ZS. Hypocalcemia. In: Rose BD, editor. UpToDate. Welleslay: UpToDate; 2004. pp. 1-24.
32. Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla F. Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 2004; 38:1002-1005.
33. Armelisasso C, Vaccario ML, Pontecorvi A, Mazza A. Tonic-clonic seizures in a patient with primary hypoparathyroidism: a case report. Clin EEG Neurosci 2004; 35:97-99.
34. Christiansen C, Rodbro P, Sjo O. 'Anticonvulsant action' of vitamin D in epileptic patients? A controlled pilot study. Br Med J 1974; 2:258-259.
35. Offermann G, Pinto V, Kruse R. Antiepileptic drugs and vitamin D supplementation. Epilepsia 1979; 20:3-15.
36. Kalueff AV, Minasyan A, Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res Bull 2005; 67:156-160.
37. 3. Free Radic Biol Chem 2003; 34:1416-1425.
38. Lin AM, Chen KB, Chao PL. Antioxidative effect of vitamin D on zinc-induced oxidative stress in CNS. Ann N Y Acad Sci 2005; 1053:319-329.
39. McCarty MF. Down-regulation of microglial activation may represent a practical strategy for combating neurodegenerative disorders. Med Hypotheses 2006; 67:251-269.
40. 3 on the expression of HO-1 and GFAP in glial cells of the photothrombotically lesioned cerebral cortex. J Chem Neuroanat 2004; 28:225-238.
41. 3 treatment does not alter neuronal cyclooxygenase-2 expression in the cerebral cortex after stroke. Anat Embryol 2006; 211:129-137. This is an interesting study further confirming neuroprotective role of vitamin D and exploring in detail underlying mechanisms for such actions.
42. Sutherland MK, Somerville MJ, Yoong LK, et al. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Mol Brain Res 1992; 13:239-250.
43. 3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons. J Neurosci Res 2006; 83:1179-1189. This study reports protective effects of chronic vitamin D treatment against glutamate neurotoxicity in cultured rat cortical neurons (accompanied by upregulation of VDRs), suggesting that long-term vitamin D supplementation may protect against glutamate toxicity in the CNS.
44. 3 on the seizure-induced changes in brain gene expression and immune activity in the rat. Brain Res 2005; 1039:1-13. An interesting study giving an example of biological activity of low-calcemic vitamin D analogs and outlining their potential utility in neuroprotection and immunomodulation.
45. 3 to suppress experimental autoimmune encephalomyelitis in mice. Arch Biochem Biophys 2002; 408:200-204.
46. 3 acts as an anti-inflammatory agent in the hippocampus, reversing age-related activation of microglia and the accompanying increase in interleukin-1β.
47. DiMario FJ, Clancy R. Symmetrical thalamic degeneration with calcifications of infancy. Am J Dis Child 1989; 143:1056-1060.
48. Harzy T, Benbouazza K, Amine B, et al. Idiopathic hypoparathyroidism and adhesive capsulitis of the shoulder in two first-degree relatives. Joint Bone Spine 2004; 71:234-236.
49. Manyam BV, Walters AS, Narla KR. Bilateral striopallidodentate calcinosis: clinical characteristics of patients seen in a registry. Mov Disord 2001; 16:258-264.
50. Martinelli P, Giuliani S, Ippoliti M, et al. Familial idiopathic strio-pallido-dentate calcifications with late onset extrapyramidal syndrome. Mov Disord 1993; 8:220-222.
51. Vakaet A, Rubens R, De Reuck J, Vander Eecken H. Intracranial bilateral symmetrical calcification on CT-scanning. A case report and a review of the literature. Clin Neurol Neurosurg 1985; 87:103-111.
52. Kalueff A, Loseva E, Haapasalo H, et al. Thalamic calcification in vitamin D receptor knockout mice. Neuroreport 2006; 17:717-721. This study links VDR genetic ablation to brain calcification in mice. Insensitivity to vitamin D action due to receptor knockout may be relevant to mimicking similar brain disorders in vitamin D deficiency.
53. Armstrong DJ, Meenagh GK, Bickle I, et al. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2006; DOI: 10.1007/s10067-006-0348-5. A particularly important recent study showing that fibromyalgia patients with vitamin D deficiency (below 25 nmol/l) have higher anxiety and depression than patients with insufficient or normal levels of vitamin D. These data strongly, although indirectly, confirm the link between vitamin D status and emotional/affective disorders.
54. Gloth FM, Alam W, Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 2001; 3:5-7.
55. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 2004; 15:1271-1274.
56. 3 enhances mood in healthy subjects during winter. Psychopharmacology 1998; 135:319-323.
57. 3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Am J Clin Nutr 2004; 80:1752S-1758S.
58. Van Os J, Krabbendam L, Myin-Germeys I, Delespaul P. The schizophrenia envirome. Curr Opin Psychiatry 2005; 18:141-145.
59. The Vitamin D Council. Understanding vitamin D: cholecalciferol [online]. Atascadero: The Vitamin D Council; 2006; http://www.vitamindcouncil.com. A useful web-resource on vitamin D, run by a group of concerned scientists who believe many humans are needlessly suffering and dying from Vitamin D deficiency. Their goal is to educate the public and professionals about vitamin D and the numerous diseases associated with its deficiency.
60. Yan J, Feng J, Craddock N, et al. Vitamin D receptor variants in 192 patients with schizophrenia and other psychiatric diseases. Neurosci Lett 2005; 380:37-41. This study examined VDR gene polymorphisms in psychiatric patients, describing novel structural variants of the receptor in some of these patients.
61. Ozer S, Ulusahin A, Ulusoy S, et al. Is vitamin D hypothesis for schizophrenia valid? Independent segregation of psychosis in a family with vitamin D-dependent rickets type IIA. Prog Neuropsychopharmacol Biol Psychiatry 2004; 28:255-266.
62. 3. Hum Exp Toxicol 1996; 15:573-576.
63. Csaba G, Inczefi-Gonda A. Molecules acting on receptor level at weaning, durably influence liver glucocorticoid receptors. Acta Physiol Hung 2005; 92:33-38.
64. 3 on metabolism and D-glucose transport in rat cerebral cortex. J Neurochem Res 1993; 35:559-566.
65. Jorde R, Waterloo K, Saleh F, et al. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: the Tromso study. J Neurol 2006; 253:464-470.
66. Arlt W, Fremerey C, Callies F, Reincke M, et al. Well being, mood and calcium homeostasis in patients with hypoparathyroidism receiving standard treatment with calcium and vitamin D. Eur J Endocrinol 2002; 146:215-222.
67. Stumpf WE, Privette TH. The steroid hormone of sunlight soltriol (vitamin D) as a seasonal regulator of biological activities and photoperiodic rhythms. J Steroid Biochem Mol Biol 1991; 39:283-289.
68. Kim JS, Kim YI, Song C, et al. Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J Korean Med Sci 2005; 20:495-498. An important study reporting an association between VDR genetic polymorphisms and Parkinsonism.
69. Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet 2005; 19:25-38. This study examined VDR gene polymorphisms in an Australian population and links genetic variation in this gene to increased risks of developing MS, particularly its progressive clinical subtypes.
70. Fukazawa T, Yabe I, Kikuhi K, et al. Association of vitamin D receptor gene polymorphism with multiple sclerosis in Japanese. J Neurol Sci 1999; 166:47-52.
71. Hayes CE. Vitamin D: a natural inhibitor of multiple sclerosis. Proc Nutr Soc 2000; 59:531-535.
72. Munger KL, Zhang SM, O'Reilly, et al. Vitamin D intake and incidence of multiple sclerosis. Neurol 2004; 62:60-65.
73. Van Amerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004; 58:1095-1109.
74. 3) for relapsing-remitting multiple sclerosis. J Neurol Neurosurg Psychiatry 2005; 76:1294-1296. An interesting report showing that vitamin D dietary supplementation may be effective in relapsing-remitting MS.
75. McCarty MF. Toward prevention of Alzheimers disease - potential nutraceutical strategies for suppressing the production of amyloid beta peptides. Med Hypotheses 2006; 67:682-697. An interesting review discussing various dietary factors to treat Alzheimer's disease, also noting potential importance of vitamin D status and supplementation.
76. Symonds ME, Gardner DS. Experimental evidence for early nutritional programming of later health in animals. Curr Opin Clin Nutr Metab Care 2006; 9:278-283. A good review of animal models in clinical nutrition, particularly focusing on perinatal effects.
77. Kesby JP, Burne THJ, McGrath JJ, Eyles DW. Developmental vitamin D deficiency alters MK-801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol Psychiatry 2006; DOI: 10.1016/j.biopsych.2006.02. 033. An interesting study linking prenatal vitamin D deficit to spontaneous and drug-induced hyperactivity in rats. In general, these findings may be related to a wide range of behavioral disorders, in which vitamin D deficits, especially during early development, may play a causative role.
78. Burne TH, Feron F, Brown J, et al. Combined prenatal and chronic postnatal vitamin D deficiency in rats impairs prepulse inhibition of acoustic startle. Physiol Behav 2004; 81:651-655.
79. Burne TH, Becker A, Brown J, et al. Transient prenatal vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav Brain Res 2004; 154:549-555.
80. Becker A, Eyles DW, McGrath JJ, Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav Brain Res 2005; 161:306-312. This study assessed learning and memory in adult rats exposed to transient prenatal vitamin D deficiency, showing that prenatally deplete animals had a significant impairment of latent inhibition, while deplete animals showed impaired hole-board habituation, but a better learning of brightness discrimination in a Y-chamber.
81. Becker A, Grecksch G. Pharmacological treatment to augment hole board habituation in prenatal vitamin D-deficient rats. Behav Brain Res 2006; 166:177-183. An interesting study examining neurocognitive impairments in rats due to developmental vitamin D deficiency, also showing the utility of this model for detecting the effect of antipsychotic drugs and differentiating between typical and atypical antipsychotics.
82. Kalueff AV. Behavioural abnormalities in mice lacking nuclear vitamin D receptors. Tampere: Tampere University Press; 2005. A detailed evaluation of behavioral anomalies observed in VDR knockout mice.
83. Burne TH, McGrath JJ, Eyles DW, Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav Brain Res 2005; 157:299-308.
84. Kalueff AV, Keisala T, Minasyan A, et al. Behavioural anomalies in mice evoked by 'Tokyo' disruption of the Vitamin D receptor gene. Neurosci Res 2006; 54:254-260. Updated summary of behavioral anomalies observed in VDR knockout mice.
85. Burne TH, Johnston AN, McGrath JJ, Mackay-Sim A. Swimming behavior and postswimming activity in vitamin D receptor knockout mice. Brain Res Bull 2006; 69:74-78. A detailed examination of motor functions in VDR mutant mice.
86. Keisala T, Minasyan A, Järvelin U, et al. Nest building and prolactin in Vitamin D receptor mutant mice. J Steroid Biochem Mol Biol Conf Proc 2006; 46.
87. Johnson MA. Nutrition and aging - practical advice for healthy eating. J Am Med Womens Assoc 2004; 59:262-269.
88. 2+-mediated hippocampal biomarkers of ageing. Cell Calcium 2006; 40:277-286. This study shows that 1,25-D regulates calcium-dependent processes in neurons, reducing age-related changes associated with calcium disregulation. These findings suggest that vitamin D-related compounds may have therapeutic implications in the brain during ageing.
89. Razzaque MS, Sitara D, Taguchi T, et al. Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 2006; 20:720-722.
90. Razzaque MS, Lanske B. Hypervitaminosis D and premature aging: lessons learned from Fgf23 and Klotho mutant mice. Trends Mol Med 2006; 12:298-305.
91. Nabeshima Y. Toward a better understanding of Klotho. Sci Aging Knowledge Environ 2006; 8:11.
92. Tsujikawa H, Kurotaki Y, Fujimori T, et al. Klotho, a gene related to a syndrome resembling human premature aging, functions in a negative regulatory circuit of vitamin D endocrine system. Mol Endocrinol 2003; 17:2393-2403.
93. Yoshida T, Fujimori T, Nabeshima Y. Mediation of unusually high concentrations of 1,25-dihydroxyvitamin D in homozygous klotho mutant mice by increased expression of renal 1alpha-hydroxylase gene. Endocrinology 2002; 143:683-689.
94. Li SA, Watanabe M, Yamada H, et al. Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice. Cell Struct Funct 2004; 29:91-99.
95. Brain Gene Expression Map. Mouse brain gene expression map [online]. Memphis: St Jude Children's Research Hospital; 2006. http://www.stjudebgem.org.
96. Anamizu Y, Kawaguchi H, Seichi A, et al. Klotho insufficiency causes decrease of ribosomal RNA gene transcription activity, cytoplasmic RNA and rough ER in the spinal anterior horn cells. Acta Neuropathol 2005; 109:457-466.
97. Nagai T, Yamada K, Kim HC, et al. Cognition impairment in the genetic model of aging klotho gene mutant mice: a role of oxidative stress. FASEB J 2003; 17:50-52.
98. Deary IJ, Harris SE, Fox HC, et al. KLOTHO genotype and cognitive ability in childhood and old age in the same individuals. Neurosci Lett 2005; 378:22-27.
99. Shimokata H, Ando F, Fukukawa Y, Nishita Y. Klotho gene promoter polymorphism and cognitive impairment. Geriatr Gerontol Int 2006; 6:136-141.
100. Kalueff AV, Eremin KO, Tuohimaa P. Brain effects of vitamin D. Conf Neuroendocrinol 2004; 2:158-159.
101. 3 (soltriol) levels influence serotonin levels in the hypothalamus of the rat. Abstr Soc Neurosci 1991; 17:498.
102. Kalueff AV, Minasyan A, Keisala T, et al. Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci Lett 2006; 394:69-73.
103. Holick MF. The vitamin D epidemic and its health consequences. J Nutr 2005; 135:2739S-2748S.
104. Holmes RP, Kummerow FA. The relationship of adequate and excessive intake of vitamin D to health and disease. J Am Coll Nutr 1983; 2:173-199.
105. Zittermann A. Vitamin D in preventive medicine: are we ignoring the evidence? Br J Nutr 2003; 89:552-555.